When Roy Bradley was told he had cancer in his lungs and liver, his first thought was he couldn't face chemotherapy and ...

LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Among patients with non-muscle-invasive bladder cancer (NMIBC), neoadjuvant treatment with mitomycin C prior to transurethral ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

But as beachgoers prepare to pack their bags, Northwell Health’s Dr. Bhuvanesh Singh is urging them to ensure that important ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...

George Warren, PhD, Lead Author and Principal Scientist at Artelo, said, “We are excited to share the results on this novel target in psoriasis. Our findings demonstrate that ART26.12 has effects ...

A laser used in cosmetic dermatology for nearly 40 years showed properties similar to those seen with other types of lasers.

Not all zombie skin cells are the same. New research reveals three unique subtypes with different roles in aging and disease, ...

Skin cancer is by far the most common type of cancer, according to the American Cancer Society, and it’s also on the rise. We ...